EffRx will be attending CPHI 2026, taking place from October 6–8, in Milan. CPHI is one of the world’s largest gatherings for the pharmaceutical industry, bringing together companies and decision-makers from across the pharmaceutical value chain. It provides an important opportunity to strengthen existing partnerships, explore new business opportunities and discuss developments shaping the future of the industry.

At CPHI Milan, EffRx will be actively exploring in-licensing and partnership opportunities for Switzerland and Europe, particularly in niche and specialty therapeutic areas including rare diseases, endocrinology, metabolic and musculoskeletal disorders. Our focus is primarily on late-stage and commercial-stage assets where a dedicated Swiss or European commercialization approach can create value.

EffRx is also seeking partners to commercialize Binosto® in the US, Latin America and selected Asian markets, including South Korea.